{"id":1447,"date":"2018-04-26T00:00:00","date_gmt":"2018-04-25T22:00:00","guid":{"rendered":"https:\/\/www.ship2b.org\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health"},"modified":"2025-02-08T01:10:43","modified_gmt":"2025-02-08T00:10:43","slug":"onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health","status":"publish","type":"post","link":"https:\/\/www.ship2b.org\/en\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/","title":{"rendered":"Onalabs, Paperdrop DX, Admit Therapeutics, Mangrana Ventures y uCare seleccionadas para el #LABTech4Health"},"content":{"rendered":"\n<p>El pasado 4 de marzo, el <a href=\"http:\/\/ship2b.org\/tech4health\">LAB Tech4Health<\/a> cerr\u00f3 su convocatoria para startups de impacto social en el \u00e1mbito de la salud tras recibir m\u00e1s de <strong>110 candidaturas<\/strong> de todo el territorio espa\u00f1ol.<\/p>\n\n\n\n<p>Tras su revisi\u00f3n, se preseleccionaron un total de <strong>10 proyectos<\/strong>, las cuales participaron en una jornada presencial que tuvo lugar, durante dos d\u00edas, en las instalaciones de Ship2B. El comit\u00e9 de selecci\u00f3n del LAB, formado por los partners cofundadores del LAB Tech4Health (<strong>Ship2B, DKV, Esteve, Medichem, Hospital Sant Joan de Deu, Caixa Capital Risc y Nae<\/strong>) y expertos especializados, eligi\u00f3 las cinco mejores startups: <strong>Onalabs, Paperdrop DX, Admit Therapeutics, Mangrana Ventures y uCare.<\/strong><\/p>\n\n\n\n<p>Durante los pr\u00f3ximos meses, cada una de ellas recibir\u00e1 <strong>asesoramiento de profesionales<\/strong> expertos en el sector y se potenciar\u00e1 la generaci\u00f3n de <strong>alianzas<\/strong> con grandes empresas y entidades p\u00fablicas con el fin de impulsar su crecimiento. Adem\u00e1s, el equipo de inversi\u00f3n de Ship2B analizar\u00e1 cada una de las startups para realizar una <strong>inversi\u00f3n inicial de 40.000?<\/strong> en los primeros meses y hasta un total de <strong>400.000? en rondas posteriores<\/strong>. Esta inversi\u00f3n se realizar\u00e1 por parte de Impact Equity BF, veh\u00edculo de inversi\u00f3n gestionado por Ship2B.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Las 5 startups seleccionadas:<\/h4>\n\n\n\n<p><strong><a href=\"https:\/\/www.onalabs.com\/\">Onalabs<\/a> (Barcelona)<\/strong>: Es la primera soluci\u00f3n de monitorizaci\u00f3n no invasiva que mediante biosensores miniaturizados mide cualquier par\u00e1metro qu\u00edmico presente en el sudor. Pone el foco de atenci\u00f3n en tres de las cuatro principales Enfermedades No Transmisibles (ENT) identificadas por la OMS que matan a 40 millones de personas cada a\u00f1o, lo que equivale al 70% de las muertes que se producen en todo el mundo.<\/p>\n\n\n\n<p><strong>Paperdrop XD (Barcelona)<\/strong>:&nbsp;Plataforma spin-off del Institut Catal\u00e0 de Nanoci\u00e8ncia i Nanotecnologia que dise\u00f1a dispositivos diagn\u00f3sticos de bajo coste y basados en papel, con una primera aplicaci\u00f3n que identificar\u00e1 el riesgo de ictus isqu\u00e9mico.<\/p>\n\n\n\n<p><strong><a href=\"http:\/\/www.admit-therapeutics.com\/en\">Admit therapeutics<\/a> (Barcelona)<\/strong>: Desarrollan y comercializan una novedosa tecnolog\u00eda de detecci\u00f3n temprana de la enfermedad de Alzheimer.<\/p>\n\n\n\n<p><strong><a href=\"http:\/\/mangranaventures.com\/\">Mangrana Ventures<\/a> (Barcelona)<\/strong>: Plataforma escalable y disruptiva que brinda soluciones amigables para ayudar a los ciudadanos a combinar sus necesidades de salud, bienestar y felicidad. Construido alrededor de estas tres \u00e1reas principales, utiliza inteligencia profesional y artificial.<\/p>\n\n\n\n<p><strong><a href=\"https:\/\/u-carehealth.com\/es\/inicio\/\">UCare<\/a> (Madrid)<\/strong>: ofrece soluciones de e-health basadas en Inteligencia Artificial, con el objetivo transformar los servicios de salud para hacerlos m\u00e1s eficientes e incrementar su accesibilidad para el paciente.<\/p>\n\n\n\n<hr class=\"wp-block-separator\" \/>\n\n\n\n<h4 class=\"wp-block-heading\">LAB Tech4Health<\/h4>\n\n\n\n<p><strong>DKV, Esteve, Medichem, Hospital Sant Joan de Deu, Caixa Capital Risc y Nae<\/strong> son los partners cofundadores del LAB Tech4Health, plataforma de inversi\u00f3n y aceleraci\u00f3n para startups en el \u00e1mbito de la salud que, actualmente, cuenta con <strong>18 startups<\/strong> que han conseguido cerrar <strong>rondas por valor de 9,28M?<\/strong>. <strong>Visualfy, MJN Neuroserveis y Cebiotex<\/strong>, son algunos de los proyectos de \u00e9xito seleccionados en las anteriores convocatorias del programa.<\/p>\n\n\n\n<p>La pr\u00f3xima entrada de proyectos se realizar\u00e1 en septiembre, y las startups interesadas podr\u00e1n <strong>presentar su candidatura hasta el 15 de julio<\/strong>. Toda la informaci\u00f3n se encuentra en <a href=\"http:\/\/ship2b.org\/tech4health\">ship2b.org\/tech4health<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El pasado 4 de marzo, el LAB Tech4Health cerr\u00f3 su convocatoria para startups de impacto social en el \u00e1mbito de la salud tras recibir m\u00e1s de 110 candidaturas de todo el territorio espa\u00f1ol. Tras su revisi\u00f3n, se preseleccionaron un total de 10 proyectos, las cuales participaron en una jornada presencial que tuvo lugar, durante dos &hellip; <a href=\"https:\/\/www.ship2b.org\/en\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/\">Read more<\/a><\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[27,191],"tags":[184,186],"class_list":["post-1447","post","type-post","status-publish","format-standard","hentry","category-aceleracion","category-salud-y-calidad-de-vida","tag-s2b-tech4social","tag-s2b-tech4health"],"acf":[],"yoast_head":"<title>Onalabs, Paperdrop DX, Admit Therapeutics, Mangrana Ventures y uCare seleccionadas para el #LABTech4Health - Ship2B Foundation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Onalabs, Paperdrop DX, Admit Therapeutics, Mangrana Ventures y uCare seleccionadas para el #LABTech4Health - Ship2B Foundation\" \/>\n<meta property=\"og:description\" content=\"El pasado 4 de marzo, el LAB Tech4Health cerr\u00f3 su convocatoria para startups de impacto social en el \u00e1mbito de la salud tras recibir m\u00e1s de 110 candidaturas de todo el territorio espa\u00f1ol. Tras su revisi\u00f3n, se preseleccionaron un total de 10 proyectos, las cuales participaron en una jornada presencial que tuvo lugar, durante dos &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/\" \/>\n<meta property=\"og:site_name\" content=\"Ship2B Foundation\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-25T22:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-08T00:10:43+00:00\" \/>\n<meta name=\"author\" content=\"monolitdigital\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"monolitdigital\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/\",\"url\":\"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/\",\"name\":\"Onalabs, Paperdrop DX, Admit Therapeutics, Mangrana Ventures y uCare seleccionadas para el #LABTech4Health - Ship2B Foundation\",\"isPartOf\":{\"@id\":\"https:\/\/www.ship2b.org\/#website\"},\"datePublished\":\"2018-04-25T22:00:00+00:00\",\"dateModified\":\"2025-02-08T00:10:43+00:00\",\"author\":{\"@id\":\"https:\/\/www.ship2b.org\/#\/schema\/person\/5e1e3cfe72b47ae1bcbc7b9d714051bb\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.ship2b.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Onalabs, Paperdrop DX, Admit Therapeutics, Mangrana Ventures y uCare seleccionadas para el #LABTech4Health\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ship2b.org\/#website\",\"url\":\"https:\/\/www.ship2b.org\/\",\"name\":\"Ship2B Foundation\",\"description\":\"Adventurers for a better world\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ship2b.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ship2b.org\/#\/schema\/person\/5e1e3cfe72b47ae1bcbc7b9d714051bb\",\"name\":\"monolitdigital\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ship2b.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/946a2b9f66f4160be08b4f9a06887503c98ef66c5b9b64ee89d92fc57ef7eb18?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/946a2b9f66f4160be08b4f9a06887503c98ef66c5b9b64ee89d92fc57ef7eb18?s=96&d=mm&r=g\",\"caption\":\"monolitdigital\"},\"url\":\"https:\/\/www.ship2b.org\/en\/actualidad\/author\/monolitdigital\/\"}]}<\/script>","yoast_head_json":{"title":"Onalabs, Paperdrop DX, Admit Therapeutics, Mangrana Ventures y uCare seleccionadas para el #LABTech4Health - Ship2B Foundation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/","og_locale":"en_US","og_type":"article","og_title":"Onalabs, Paperdrop DX, Admit Therapeutics, Mangrana Ventures y uCare seleccionadas para el #LABTech4Health - Ship2B Foundation","og_description":"El pasado 4 de marzo, el LAB Tech4Health cerr\u00f3 su convocatoria para startups de impacto social en el \u00e1mbito de la salud tras recibir m\u00e1s de 110 candidaturas de todo el territorio espa\u00f1ol. Tras su revisi\u00f3n, se preseleccionaron un total de 10 proyectos, las cuales participaron en una jornada presencial que tuvo lugar, durante dos &hellip; Read more","og_url":"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/","og_site_name":"Ship2B Foundation","article_published_time":"2018-04-25T22:00:00+00:00","article_modified_time":"2025-02-08T00:10:43+00:00","author":"monolitdigital","twitter_card":"summary_large_image","twitter_misc":{"Written by":"monolitdigital","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/","url":"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/","name":"Onalabs, Paperdrop DX, Admit Therapeutics, Mangrana Ventures y uCare seleccionadas para el #LABTech4Health - Ship2B Foundation","isPartOf":{"@id":"https:\/\/www.ship2b.org\/#website"},"datePublished":"2018-04-25T22:00:00+00:00","dateModified":"2025-02-08T00:10:43+00:00","author":{"@id":"https:\/\/www.ship2b.org\/#\/schema\/person\/5e1e3cfe72b47ae1bcbc7b9d714051bb"},"breadcrumb":{"@id":"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ship2b.org\/actualidad\/onalabs-paperdrop-dx-admit-therapeutics-mangrana-ventures-y-ucare-seleccionadas-para-el-labtech4health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ship2b.org\/en\/"},{"@type":"ListItem","position":2,"name":"Onalabs, Paperdrop DX, Admit Therapeutics, Mangrana Ventures y uCare seleccionadas para el #LABTech4Health"}]},{"@type":"WebSite","@id":"https:\/\/www.ship2b.org\/#website","url":"https:\/\/www.ship2b.org\/","name":"Ship2B Foundation","description":"Adventurers for a better world","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ship2b.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.ship2b.org\/#\/schema\/person\/5e1e3cfe72b47ae1bcbc7b9d714051bb","name":"monolitdigital","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ship2b.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/946a2b9f66f4160be08b4f9a06887503c98ef66c5b9b64ee89d92fc57ef7eb18?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/946a2b9f66f4160be08b4f9a06887503c98ef66c5b9b64ee89d92fc57ef7eb18?s=96&d=mm&r=g","caption":"monolitdigital"},"url":"https:\/\/www.ship2b.org\/en\/actualidad\/author\/monolitdigital\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/posts\/1447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/comments?post=1447"}],"version-history":[{"count":2,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/posts\/1447\/revisions"}],"predecessor-version":[{"id":15158,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/posts\/1447\/revisions\/15158"}],"wp:attachment":[{"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/media?parent=1447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/categories?post=1447"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/tags?post=1447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}